Recent Quarter Total Invested
$6.25 B
Recent Quarter Institutional Ownership Percentage
104.99%
Total Invested of Last Quarter
$6.84 B
Ownership Percentage of Last Quarter
98.41%
Ionis Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2024 | 14.17 M | $567.58 M | 12.09% | 9.53% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 10.81 M | $433.17 M | 100.00% | 7.28% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 8.74 M | $349.96 M | 32.99% | 5.88% |
| BELLEVUE GROUP AG | 11/14/2024 | 7.87 M | $315.45 M | -4.67% | 5.30% |
| CAPITAL WORLD INVESTORS | 11/13/2024 | 7.83 M | $313.60 M | 247.60% | 5.27% |
| STATE STREET CORP | 11/14/2024 | 4.85 M | $194.30 M | 15.74% | 3.26% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 4.21 M | $168.66 M | 7.01% | 2.83% |
| TWEEDY, BROWNE CO LLC | 11/13/2024 | 3.45 M | $138.39 M | 0.00% | 2.32% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 2.67 M | $106.92 M | 7.40% | 1.80% |
| ORBIMED ADVISORS LLC | 11/14/2024 | 2.32 M | $93.12 M | -2.02% | 1.56% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 11/12/2024 | 2.24 M | $89.75 M | 34.08% | 1.51% |
| DEEP TRACK CAPITAL, LP | 11/14/2024 | 2.20 M | $88.13 M | 10.00% | 1.48% |
| MARSHALL WACE, LLP | 11/14/2024 | 1.92 M | $76.93 M | 1,008.82% | 1.29% |
| MACQUARIE GROUP LTD | 11/14/2024 | 1.87 M | $74.90 M | -0.21% | 1.26% |
| CLEARBRIDGE INVESTMENTS, LLC | 11/12/2024 | 1.70 M | $68.20 M | -21.20% | 1.15% |
| BVF INC/IL | 11/14/2024 | 1.45 M | $58.16 M | -54.43% | 0.98% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 1.44 M | $57.81 M | 8.65% | 0.97% |
| ARK INVESTMENT MANAGEMENT LLC | 10/31/2024 | 1.38 M | $55.45 M | 1.71% | 0.93% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 1.33 M | $53.38 M | 3.52% | 0.90% |
| MORGAN STANLEY | 11/14/2024 | 1.31 M | $52.50 M | 29.39% | 0.88% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 1.30 M | $52.72 M | -45.91% | 0.88% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 1.09 M | $44.65 M | 14.72% | 0.74% |
| CANDRIAM S.C.A. | 11/13/2024 | 948,266 | $37.99 M | 0.00% | 0.64% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 919,077 | $36.82 M | -10.61% | 0.62% |
| GROUPAMA ASSET MANAGMENT | 11/15/2024 | 916,060 | $13.80 B | 141.08% | 0.62% |
| INVESCO LTD. | 11/12/2024 | 810,301 | $32.46 M | -16.37% | 0.55% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 11/08/2024 | 779,721 | $31.24 M | -0.13% | 0.52% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 11/13/2024 | 766,900 | $30.72 M | 109.54% | 0.52% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2024 | 750,000 | $30.05 M | 150.00% | 0.50% |
| ROYAL BANK OF CANADA | 11/14/2024 | 670,149 | $26.85 M | -1.21% | 0.45% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 650,779 | $26.07 M | 13.60% | 0.44% |
| BARCLAYS PLC | 11/19/2024 | 637,032 | $25.52 M | 3.47% | 0.43% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 610,893 | $24.47 M | 2.25% | 0.41% |
| J. GOLDMAN & CO LP | 11/14/2024 | 609,416 | $24.41 M | 3,381.98% | 0.41% |
| MAN GROUP PLC | 11/14/2024 | 596,263 | $23.89 M | -5.86% | 0.40% |
| JPMORGAN CHASE & CO | 11/08/2024 | 568,906 | $22.79 M | -4.24% | 0.38% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 568,660 | $22.78 M | 10.52% | 0.38% |
| AXA S.A. | 11/14/2024 | 561,243 | $22.48 M | 20.71% | 0.38% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 500,000 | $20.03 M | -37.50% | 0.34% |
| ECOR1 CAPITAL, LLC | 11/14/2024 | 500,000 | $20.03 M | 100.00% | 0.34% |
| EVERSEPT PARTNERS, LP | 11/14/2024 | 471,355 | $18.88 M | 3.17% | 0.32% |
| PINNACLE ASSOCIATES LTD | 10/25/2024 | 458,979 | $23.22 M | 1.24% | 0.31% |
| NOMURA HOLDINGS INC | 11/14/2024 | 453,069 | $18.15 M | -9.60% | 0.30% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 430,723 | $17.25 M | 235.94% | 0.29% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 11/08/2024 | 406,870 | $16.30 M | 80.77% | 0.27% |
| FIRST TRUST ADVISORS LP | 11/13/2024 | 402,300 | $16.12 M | 2,384.25% | 0.27% |
| CITADEL ADVISORS LLC | 11/14/2024 | 401,151 | $16.07 M | -36.02% | 0.27% |
| GHISALLO CAPITAL MANAGEMENT LLC | 11/14/2024 | 400,000 | $16.02 M | 100.00% | 0.27% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 397,898 | $15.94 M | 4,425.68% | 0.27% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 380,641 | $15.25 M | 100.00% | 0.26% |
Ionis Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of IONS shares?
During the previous two years, 485 institutional investors and hedge funds held shares of Ionis Pharmaceuticals, Inc.. The most heavily invested institutionals were:
T. Rowe Price Investment Management, Inc.: 14.17 M
BlackRock Funding, Inc. /DE: 10.81 M
WELLINGTON MANAGEMENT GROUP LLP: 8.74 M
Bellevue Group AG: 7.87 M
Capital World Investors: 7.83 M
STATE STREET CORP: 4.85 M
-
What percentage of Ionis Pharmaceuticals, Inc. stock is owned by institutional investors?
104.99% of Ionis Pharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at IONS ?
Institutional investors have bought a total of 149.83 M shares in the last 24 months. This purchase volume represents approximately $5.09 B in transactions.